The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

INTRODUCTION: Sodium-glucose co-transporter 2 inhibitors (SGLT-2i) increase urinary glucose excretion through a reduced renal glucose reabsorption. We plan to perform a systematic review of SGLT-2i for treatment of type 2 diabetes. METHODS AND ANALYSIS: A systematic review with meta-analyses of rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Storgaard, Heidi, Gluud, Lise Lotte, Christensen, Mikkel, Knop, Filip Krag, Vilsbøll, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139650/
https://www.ncbi.nlm.nih.gov/pubmed/25232561
http://dx.doi.org/10.1136/bmjopen-2014-005378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139650/
https://www.ncbi.nlm.nih.gov/pubmed/25232561
http://dx.doi.org/10.1136/bmjopen-2014-005378

Ejemplares similares